Clinical Trial Update: A Clinical Trial of Antibody GSK1070806 in the Treatment of Patients With Moderate to Severe Crohn's Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the antibody GSK1070806 for moderate to severe Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• GSK1070806

Snippet

Sponsor: University of Birmingham | Conditions: Crohn Disease | Phase 1, Phase 2 | Status: COMPLETED